Spectral Medical Provides January Tigris Trial Update
Strong enrollment activity to start 2025 146 patients enrolled TORONTO, Canada – February 3, 2025 – Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT),a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today...
